
Ansell Ltd
ASX:ANN


to continue ANN research
to continue ANN research
You've reached your weekly stock limit.
Sign UpAnsell Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.37
37.77
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Ansell Ltd hold over its rivals?
What risks and challenges
does Ansell Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Ansell Ltd.
Provide an overview of the primary business activities
of Ansell Ltd.
What unique competitive advantages
does Ansell Ltd hold over its rivals?
What risks and challenges
does Ansell Ltd face in the near future?
Has there been any significant insider trading activity
in Ansell Ltd recently?
Summarize the latest earnings call
of Ansell Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Ansell Ltd.
Provide P/S
for Ansell Ltd.
Provide P/E
for Ansell Ltd.
Provide P/OCF
for Ansell Ltd.
Provide P/FCFE
for Ansell Ltd.
Provide P/B
for Ansell Ltd.
Provide EV/S
for Ansell Ltd.
Provide EV/GP
for Ansell Ltd.
Provide EV/EBITDA
for Ansell Ltd.
Provide EV/EBIT
for Ansell Ltd.
Provide EV/OCF
for Ansell Ltd.
Provide EV/FCFF
for Ansell Ltd.
Provide EV/IC
for Ansell Ltd.
Show me price targets
for Ansell Ltd made by professional analysts.
What are the Revenue projections
for Ansell Ltd?
How accurate were the past Revenue estimates
for Ansell Ltd?
What are the Net Income projections
for Ansell Ltd?
How accurate were the past Net Income estimates
for Ansell Ltd?
What are the EPS projections
for Ansell Ltd?
How accurate were the past EPS estimates
for Ansell Ltd?
What are the EBIT projections
for Ansell Ltd?
How accurate were the past EBIT estimates
for Ansell Ltd?
Compare the revenue forecasts
for Ansell Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Ansell Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Ansell Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Ansell Ltd compared to its peers.
Compare the P/E ratios
of Ansell Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Ansell Ltd with its peers.
Analyze the financial leverage
of Ansell Ltd compared to its main competitors.
Show all profitability ratios
for Ansell Ltd.
Provide ROE
for Ansell Ltd.
Provide ROA
for Ansell Ltd.
Provide ROIC
for Ansell Ltd.
Provide ROCE
for Ansell Ltd.
Provide Gross Margin
for Ansell Ltd.
Provide Operating Margin
for Ansell Ltd.
Provide Net Margin
for Ansell Ltd.
Provide FCF Margin
for Ansell Ltd.
Show all solvency ratios
for Ansell Ltd.
Provide D/E Ratio
for Ansell Ltd.
Provide D/A Ratio
for Ansell Ltd.
Provide Interest Coverage Ratio
for Ansell Ltd.
Provide Altman Z-Score Ratio
for Ansell Ltd.
Provide Quick Ratio
for Ansell Ltd.
Provide Current Ratio
for Ansell Ltd.
Provide Cash Ratio
for Ansell Ltd.
What is the historical Revenue growth
over the last 5 years for Ansell Ltd?
What is the historical Net Income growth
over the last 5 years for Ansell Ltd?
What is the current Free Cash Flow
of Ansell Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Ansell Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
AU |
![]() |
Ansell Ltd
ASX:ANN
|
4.4B AUD | 12.7 | |
CH |
![]() |
Alcon AG
SIX:ALC
|
34.8B CHF | 17.8 |
|
JP |
![]() |
Hoya Corp
TSE:7741
|
5.8T JPY | 17.5 |
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
136.2B DKK | 17.3 |
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
13.7B USD | 15.9 |
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
5.9B GBP | 210.6 |
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.6B CHF | 30.8 |
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
45.1B CNY | 27.9 |
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.6B USD | 10.1 |
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.5B USD | 20.7 |
|
KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.5T KRW | -61.3 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
AU |
![]() |
Ansell Ltd
ASX:ANN
|
Average EV/EBITDA:
38.1
12.7
|
27%
|
0.5 | |
CH |
![]() |
Alcon AG
SIX:ALC
|
17.8
|
10%
|
1.8 |
|
JP |
![]() |
Hoya Corp
TSE:7741
|
17.5
|
9%
|
1.9 |
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
17.3
|
9%
|
1.9 |
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
15.9
|
15%
|
1.1 |
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
210.6
|
11%
|
19.1 |
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
30.8
|
31%
|
1 |
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
27.9
|
18%
|
1.5 |
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
10.1
|
21%
|
0.5 |
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
20.7
|
12%
|
1.7 |
|
KR |
H
|
HLB Inc
KOSDAQ:028300
|
Negative Multiple: -61.3 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.